LicianPro

CGTX holders · CITADEL ADVISORS LLC 13F · CGTX stock

CITADEL ADVISORS LLC Cognition Therapeutics Inc (CGTX) 13F holding

CITADEL ADVISORS LLC reported 25,905 CGTX shares valued at $19.7K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest CGTX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the CGTX holders table.

CGTX reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-3125,905$19.7KCOM
2025-12-31161,201$217.6KCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.